Kristina N. Whisenhunt
University of Wisconsin-Madison
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kristina N. Whisenhunt.
Journal of Clinical Investigation | 2016
Tomokazu Souma; Stuart W. Tompson; Benjamin R. Thomson; Owen M. Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N. Whisenhunt; Sebastian Maurer-Stroh; Tammy L. Yanovitch; Luba Kalaydjieva; Dimitar N. Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W. Hewitt; Bethany A. Kloss; Kathryn P. Burdon; David A. Mackey; Keri F. Allen; Jonathan B Ruddle; Sing Hui Lim; Steve Rozen; Khanh Nhat Tran-Viet; Xiaorong Liu; Simon W. M. John; Janey L. Wiggs
Primary congenital glaucoma (PCG) is a devastating eye disease and an important cause of childhood blindness worldwide. In PCG, defects in the anterior chamber aqueous humor outflow structures of the eye result in elevated intraocular pressure (IOP); however, the genes and molecular mechanisms involved in the etiology of these defects have not been fully characterized. Previously, we observed PCG-like phenotypes in transgenic mice that lack functional angiopoietin-TEK signaling. Herein, we identified rare TEK variants in 10 of 189 unrelated PCG families and demonstrated that each mutation results in haploinsufficiency due to protein loss of function. Multiple cellular mechanisms were responsible for the loss of protein function resulting from individual TEK variants, including an absence of normal protein production, protein aggregate formation, enhanced proteasomal degradation, altered subcellular localization, and reduced responsiveness to ligand stimulation. Further, in mice, hemizygosity for Tek led to the formation of severely hypomorphic Schlemms canal and trabecular meshwork, as well as elevated IOP, demonstrating that anterior chamber vascular development is sensitive to Tek gene dosage and the resulting decrease in angiopoietin-TEK signaling. Collectively, these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity.
Journal of Clinical Investigation | 2017
Benjamin R. Thomson; Tomokazu Souma; Stuart W. Tompson; Tuncer Onay; Krishnakumar Kizhatil; Owen M. Siggs; Liang Feng; Kristina N. Whisenhunt; Tammy L. Yanovitch; Luba Kalaydjieva; Dimitar N. Azmanov; Simone Finzi; Christine A Tanna; Alex W. Hewitt; David A. Mackey; Yasmin S. Bradfield; Emmanuelle Souzeau; Shahrbanou Javadiyan; Janey L. Wiggs; Francesca Pasutto; Xiaorong Liu; Simon W. M. John; Jamie E. Craig; Jing Jin; Terri L. Young; Susan E. Quaggin
Primary congenital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by developmental defects in 2 aqueous humor outflow structures, Schlemm’s canal (SC) and the trabecular meshwork. We previously identified loss-of-function mutations in the angiopoietin (ANGPT) receptor TEK in families with PCG and showed that ANGPT/TEK signaling is essential for SC development. Here, we describe roles for the major ANGPT ligands in the development of the aqueous outflow pathway. We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure. By contrast, ANGPT2 was dispensable, although mice deficient in both Angpt1 and Angpt2 completely lacked SC, indicating that ANGPT2 compensates for the loss of ANGPT1. In addition, we identified 3 human subjects with rare ANGPT1 variants within an international cohort of 284 PCG patients. Loss of function in 2 of the 3 patient alleles was observed by functional analysis of ANGPT1 variants in a combined in silico, in vitro, and in vivo approach, supporting a causative role for ANGPT1 in disease. By linking ANGPT1 with PCG, these results highlight the importance of ANGPT/TEK signaling in glaucoma pathogenesis and identify a candidate target for therapeutic development.
Nature Genetics | 2018
Milly S. Tedja; Robert Wojciechowski; Pirro G. Hysi; Nicholas Eriksson; Nicholas A. Furlotte; Virginie J. M. Verhoeven; Adriana I. Iglesias; Magda A. Meester-Smoor; Stuart W. Tompson; Qiao Fan; Anthony P. Khawaja; Ching-Yu Cheng; René Höhn; Kenji Yamashiro; Adam Wenocur; Clare Grazal; Toomas Haller; Andres Metspalu; Juho Wedenoja; Jost B. Jonas; Ya Xing Wang; Jing Xie; Paul Mitchell; Paul J. Foster; Barbara E. K. Klein; Ronald Klein; Andrew D. Paterson; S. Mohsen Hosseini; Rupal L. Shah; Cathy Williams
Refractive errors, including myopia, are the most frequent eye disorders worldwide and an increasingly common cause of blindness. This genome-wide association meta-analysis in 160,420 participants and replication in 95,505 participants increased the number of established independent signals from 37 to 161 and showed high genetic correlation between Europeans and Asians (>0.78). Expression experiments and comprehensive in silico analyses identified retinal cell physiology and light processing as prominent mechanisms, and also identified functional contributions to refractive-error development in all cell types of the neurosensory retina, retinal pigment epithelium, vascular endothelium and extracellular matrix. Newly identified genes implicate novel mechanisms such as rod-and-cone bipolar synaptic neurotransmission, anterior-segment morphology and angiogenesis. Thirty-one loci resided in or near regions transcribing small RNAs, thus suggesting a role for post-transcriptional regulation. Our results support the notion that refractive errors are caused by a light-dependent retina-to-sclera signaling cascade and delineate potential pathobiological molecular drivers.Transancestral GWAS meta-analysis in 160,420 individuals identifies 139 loci associated with refractive error, including myopia. Newly identified genes implicate pathways involved in eye growth and light signaling cascades.
Ophthalmic Genetics | 2017
Stuart W. Tompson; Charles Johnson; Diana Abbott; Benjamin Bakall; Vincent Soler; Tammy L. Yanovitch; Kristina N. Whisenhunt; Thomas Klemm; Steve Rozen; Edwin M. Stone; Max R. Johnson; Terri L. Young
ABSTRACT Background: In a four-generation Caucasian family variably diagnosed with autosomal dominant (AD) Stickler or Wagner disease, commercial gene screening failed to identify a mutation in COL2A1 or VCAN. We utilized linkage mapping and exome sequencing to identify the causal variant. Materials and methods: Genomic DNA samples collected from 40 family members were analyzed. A whole-genome linkage scan was performed using Illumina HumanLinkage-24 BeadChip followed by two-point and multipoint linkage analyses using FASTLINK and MERLIN. Exome sequencing was performed on two affected individuals, followed by co-segregation analysis. Results: Parametric multipoint linkage analysis using an AD inheritance model demonstrated HLOD scores > 2.00 at chromosomes 1p36.13-1p36.11 and 12q12-12q14.1. SIMWALK multipoint analysis replicated the peak in chromosome 12q (peak LOD = 1.975). FASTLINK two-point analysis highlighted several clustered chromosome 12q SNPs with HLOD > 1.0. Exome sequencing revealed a novel nonsense mutation (c.115C>T, p.Gln39*) in exon 2 of COL2A1 that is expected to result in nonsense-mediated decay of the RNA transcript. This mutation co-segregated with all clinically affected individuals and seven individuals who were clinically unaffected. Conclusions: The utility of combining traditional linkage mapping and exome sequencing is highlighted to identify gene mutations in large families displaying a Mendelian inheritance of disease. Historically, nonsense mutations in exon 2 of COL2A1 have been reported to cause a fully penetrant ocular-only Stickler phenotype with few or no systemic manifestations. We report a novel nonsense mutation in exon 2 of COL2A1 that displays incomplete penetrance and/or variable age of onset with extraocular manifestations.
Investigative Ophthalmology & Visual Science | 2017
Bethany A. Kloss; Stuart W. Tompson; Kristina N. Whisenhunt; Krystina Quow; Samuel J. Huang; Derek M. Pavelec; Thomas Rosenberg; Terri L. Young
Purpose To identify causal gene mutations in 14 families with autosomal dominant (AD) high myopia using exome sequencing. Methods Select individuals from 14 large Caucasian families with high myopia were exome sequenced. Gene variants were filtered to identify potential pathogenic changes. Sanger sequencing was used to confirm variants in original DNA, and to test for disease cosegregation in additional family members. Candidate genes and chromosomal loci previously associated with myopic refractive error and its endophenotypes were comprehensively screened. Results In 14 high myopia families, we identified 73 rare and 31 novel gene variants as candidates for pathogenicity. In seven of these families, two of the novel and eight of the rare variants were within known myopia loci. A total of 104 heterozygous nonsynonymous rare variants in 104 genes were identified in 10 out of 14 probands. Each variant cosegregated with affection status. No rare variants were identified in genes known to cause myopia or in genes closest to published genome-wide association study association signals for refractive error or its endophenotypes. Conclusions Whole exome sequencing was performed to determine gene variants implicated in the pathogenesis of AD high myopia. This study provides new genes for consideration in the pathogenesis of high myopia, and may aid in the development of genetic profiling of those at greatest risk for attendant ocular morbidities of this disorder.
Investigative Ophthalmology & Visual Science | 2017
Terri L. Young; Bethany A. Kloss; Stuart W. Tompson; Kristina N. Whisenhunt; Samuel Huang; Krystina Quow; Derek M. Pavelec; Thomas Rosenberg
Investigative Ophthalmology & Visual Science | 2017
Seang-Mei Saw; Cheryl Ngo; Pan Hong; Wei Jie Seow; Stuart W. Tompson; Kristina N. Whisenhunt; Eranga N. Vithana; Yap Seng Chong; Fabian Yap; Veluchamy A. Barathi; Pirro G. Hysi; Terri L. Young; Neerja Karnani
Investigative Ophthalmology & Visual Science | 2017
Stuart W. Tompson; Kristina N. Whisenhunt; Alex W. Hewitt; David A. Mackey; Terri L. Young
Investigative Ophthalmology & Visual Science | 2017
Kristina N. Whisenhunt; Stuart W. Tompson; Yasmin S. Bradfield; Samuel J. Huang; Nickie Stangel; Emily C. Higuchi; Burton J. Kushner; Terri L. Young
Investigative Ophthalmology & Visual Science | 2016
Stuart W. Tompson; Tomokazu Souma; Owen M. Siggs; Sebastian Maurer-Stroh; Kristina N. Whisenhunt; Janey L. Wiggs; Francesca Pasutto; Jamie E. Craig; Susan E. Quaggin; Terri L. Young